1Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., Hamilton, W., Hiom, S., Hunter, D., Lyratzopoulos, G., Macleod, U., Mason, R., Mitchell, G., Neal, R. D., Peake, M., Roland, M., Seifert, B., Sisler, J., Sussman, J., Taplin, S., Vedsted, P., Voruganti, T., Walter, F., Wardle, J., Watson, E., Weller, D., Wender, R., Whelan, J., Whitlock, J., Wilkinson, C., de Wit, N. and Zimmermann, C. (2015) ‘The expanding role of primary care in cancer control’, The Lancet Oncology, 16:1231–72.
2Bower, M. and Waxman, J. (2015) Oncology: Lecture notes. Chichester: Wiley.
3Palmieri, C., Bird, E. and Simcock, R. (2013) ABC of Cancer Care. Chichester: Wiley-Blackwell and BMJ Books.
4Smittenaar, C. R., Petersen, K. A., Stewart, K. and Moitt, N. (2016) ‘Cancer incidence and mortality projections in the UK until 2035’, British Journal of Cancer, 115:1147–55.
5Tabernero, J., Vyas, M., Giuliani, R., Arnold, D., Cardoso, F., Casali, P. G., Cervantes, A., Eggermont, A. M., Eniu, A., Jassem, J., Pentheroudakis, G., Peters, S., Rauh, S., Zielinski, C. C., Stahel, R. A., Voest, E., Douillard, J.-Y., McGregor, K. and Ciardiello, F. (2017) ‘Biosimilars: A position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers’, ESMO Open, 1(6) e000142.
6Brown, J., Byers, T., Thompson, K., Eldridge, B., Doyle, C. and Williams, A. M. (2001) ‘Nutrition during and after cancer treatment: A guide for informed choices by cancer survivors’, CA: A Cancer Journal for Clinicians, 51:153–81.
7Schrijver, K. and Schrijver, I. (2015) Living with the Stars. Oxford: Oxford University Press.
8Cooper, C. (2016) Blood: A very short introduction. Oxford: Oxford University Press.
9Williams, G. H. and Stoeber, K. (2012) ‘The cell cycle and cancer’, The Journal of Pathology, 226:352–64.
10Armstrong, S. (2015) p53: The Gene that Cracked the Cancer Code. London: Bloomsbury.
11Masters, J. R. (2002) ‘HeLa cells 50 years on: The good, the bad and the ugly’, Nature Reviews Cancer, 2:315–19.
12Saunders, C. and Jassal, S. (2009) Breast Cancer: The facts. Oxford: Oxford University Press.
13Riley, T. R., 3rd and Bhatti, A. M. (2001) ‘Preventive strategies in chronic liver disease: Part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise’, American Family Physician, 64:1555–60.
14Javier, R. T. and Butel, J. S. (2008) ‘The history of tumor virology’, Cancer Research, 68:7693–706.
15Cancer (2012) ‘Genome Atlas Network: Comprehensive molecular portraits of human breast tumours’, Nature, 490:61–70.
16James, N. (2011) Cancer: A very short introduction. Oxford: Oxford University Press.
17Mukherjee, M. (2011) The Emperor of All Maladies: A biography of cancer. London: Fourth Estate.
18Kuru, B., Camlibel, M., Dinc, S., Gulcelik, M. A., Gonullu, D. and Alagol, H. (2008) ‘Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery’, Singapore Medical Journal, 49:904–11.
19Greener, M. (2014) ‘Tackling HPV and cervical cancer: Looking at the whole picture’, British Journal of School Nursing, 9:377–80.
20Matsumoto, K., Oki, A., Furuta, R., Maeda, H., Yasugi, T., Takatsuka, N., Mitsuhashi, A., Fujii, T., Hirai, Y., Iwasaka, T., Yaegashi, N., Watanabe, Y., Nagai, Y., Kitagawa, T., Yoshikawa, H., Japan HPV and Cervical Cancer Study Group (2011) ‘Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: A prospective cohort study’, International Journal of Cancer, 128:2898–910.
21Hajdu, S. I. (2012) ‘A note from history: Landmarks in history of cancer, part 4’, Cancer, 118:4914–28.
22Parkin, D. M. and Darby, S. C. (2011) ‘Cancers in 2010 attributable to ionising radiation exposure in the UK’, British Journal of Cancer, 105:S57–S65.
23Parkin, D. M., Boyd, L. and Walker, L. C. (2011) ‘The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010’, British Journal of Cancer, 105:S77–S81.
24Ryndock, E. J. and Meyers, C. (2014) ‘A risk for non-sexual transmission of human papillomavirus?’, Expert Review of Anti-infective Therapy, 12:1165–70.
25Powell, N., Cuschieri, K., Cubie, H., Hibbitts, S., Rosillon, D., De Souza, S. C., Molijn, A., Quint, W., Holl, K. and Fiander, A. (2013) ‘Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: A cross-sectional observational study in Wales and Scotland (UK)’, Journal of Clinical Virology, 58:571–4.
26Deligeoroglou, E., Giannouli, A., Athanasopoulos, N., Karountzos, V., Vatopoulou, A., Dimopoulos, K. and Creatsas, G. (2013) ‘HPV infection: immunological aspects and their utility in future therapy’, Infectious Diseases in Obstetric Gynecology, 2013:540850.
27Anderson, T. A., Schick, V., Herbenick, D., Dodge, B. and Fortenberry, J. D. (2014) ‘A study of human papillomavirus on vaginally inserted sex toys, before and after cleaning, among women who have sex with women and men’, Sexually Transmitted Infections, 90:529–31.
28King, E. M., Gilson, R., Beddows, S., Soldan, K., Panwar, K., Young, C., Jit, M., Edmunds, W. J. and Sonnenberg, P. (2015) ‘Oral human papillomavirus (HPV) infection in men who have sex with men: Prevalence and lack of anogenital concordance’, Sexually Transmitted Infections, 91:284–6.
29Delere, Y., Wichmann, O., Klug, S. J., van der Sande, M., Terhardt, M., Zepp, F. and Harder, T. (2014) ‘The efficacy and duration of vaccine protection against human papillomavirus: A systematic review and meta-analysis’, Deutsches Ärzteblatt International, 111:584–91.
30Bae, J.-M. and Kim, E. H. (2016) ‘Epstein-Barr virus and gastric cancer risk: A meta-analysis with meta-regression of case-control studies’, Journal of Preventive Medicine and Public Health, 49:97–107.
31Norat, T., Aune, D., Chan, D. and Romaguera, D. (2014) ‘Fruits and vegetables: Updating the epidemiologic evidence for the WCRF/AICR lifestyle recommendations for cancer prevention’, in Zappia, V. et al. (eds), Advances in Nutrition and Cancer. Berlin, Heidelberg: Springer. Pp. 35–50.
32Kenfield, S. A., Batista, J. L., Jahn, J. L., Downer, M. K., Van Blarigan, E. L., Sesso, H. D., Giovannucci, E. L., Stampfer, M. J. and Chan, J. M. (2015) ‘Development and application of a lifestyle score for prevention of lethal prostate cancer’, Journal of the National Cancer Institute, 108:pii: djv329.
33Yang, M., Kenfield, S. A., Van Blarigan, E. L., Batista, J. L., Sesso, H. D., Ma, J., Stampfer, M. J. and Chavarro, J. E. (2015) ‘Dietary patterns after prostate cancer diagnosis in relation to disease-specific and total mortality’, Cancer Prevention Research, 8:545–51.
34Cancer Research UK and UK Health Forum (2016) ‘Short and sweet: Why the government should introduce a sugary drinks tax’. Available online at: <www.ukhealthforum.org.uk/who-we-are/our-work/modelling/publications/?entryid43=54920>.
35Parkin, D. M. and Boyd, L. (2011) ‘Cancers attributable to overweight and obesity in the UK in 2010’, British Journal of Cancer, 105:S34–S37.
36Brown, J., Byers, T., Thompson, K., Eldridge, B., Doyle, C. and Williams, A. M. (2001) ‘Nutrition during and after cancer treatment: A guide for informed choices by cancer survivors’, CA: A Cancer Journal for Clinicians, 51:153–181.
37Nelson, D. E., Jarman, D. W., Rehm, J., Greenfield, T. K., Rey, G., Kerr, W. C., Miller, P., Shield, K. D., Ye, Y. and Naimi, T. S. (2013) ‘Alcohol-attributable cancer deaths and years of potential life lost in the United States’, American Journal of Public Health, 103:641–8.
38Miller, P. M., Day, T. A. and Ravenel, M. C. (2006) ‘Clinical implications of continued alcohol consumption after diagnosis of upper aerodigestive tract cancer’, Alcohol and Alcoholism, 41:140–2.
39Parkin, D. M. (2011) ‘Tobacco-attributable cancer burden in the UK in 2010’, British Journal of Cancer, 105:S6–S13.
40Inoue-Choi, M., Liao, L. M., Reyes-Guzman, C., Hartge, P., Caporaso, N. and Freedman, N. D. (2017) ‘Association of long-term, low-intensity smoking with all-cause and cause-specific mortality in the National Institutes of Health–AARP diet and health study’, JAMA Internal Medicine, 177:87–95.
41Danson, S., Rowland, C., Rowe, R., Ellis, S., Crabtree, C., Horsman, J., Wadsley, J., Hatton, M., Woll, P. and Eiser, C. (2016) ‘The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study’, Supportive Care in Cancer, 24:1507–16.
42Baser, S., Shannon, V. R., Eapen, G. A., Jimenez, C. A., Onn, A., Lin, E. and Morice, R. C. (2006) ‘Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status’, Chest, 130:1784–90.
43Montgomery, G. H., Schnur, J. B. and Kravits, K. (2013) ‘Hypnosis for cancer care: Over 200 years young’, CA: A Cancer Journal for Clinicians, 63:31–44.
44Annunziato, A. (2008) ‘DNA packaging: nucleosomes and chromatin’, Nature Education, 1:26. Available online at: <www.nature.com./scitable/topicpage/dna-packaging-nucleosomes-and-chromatin-310>
45Cybulski, C., Nazarali, S. and Narod, S. A. (2014) ‘Multiple primary cancers as a guide to heritability’, International Journal of Cancer, 135:1756–63.
46Mei, L., Du, W. and Ma, W. W. (2016) ‘Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises’, Journal of Gastrointestinal Oncology, 7:487–94.
47Tomasetti, C., Li, L. and Vogelstein, B. (2017) ‘Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention’, Science, 355:1330–4.
48Friedenson, B. (2005) ‘BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian’, Medscape General Medicine, 7:60.
49Baker, S. G. (2014) ‘A cancer theory kerfuffle can lead to new lines of research’, Journal of the National Cancer Institute, 107:pii: dju405.
50Badenhorst, J., Husband, A., Ling, J., Lindsey, L., Todd, A. and Baer, M. (2014) ‘Do patients with cancer alarm symptoms present at the community pharmacy?’, International Journal of Pharmacy Practice, 22 (suppl. 2):32.
51Borghesi, M., Ahmed, H., Nam, R., Schaeffer, E., Schiavina, R., Taneja, S., Weidner, W. and Loeb, S. (2017) ‘Complications after systematic, random, and image-guided prostate biopsy’, European Urology, 71:353–65.
52Gaylis, F., Nasseri, R., Fink, L., Calabrese, R., Dato, P. and Cohen, E. (2016) ‘Prostate biopsy complications: A dual analysis’, Urology, 93:135–40.
53Ellinger, S. (2013) ‘Micronutrients, arginine, and glutamine: Does supplementation provide an efficient tool for prevention and treatment of different kinds of wounds?’, Advances in Wound Care, 3:691–707.
54Lindley, R. (2008) Stroke: The facts. Oxford: Oxford University Press.
55Kumar, S., Selim, M. H. and Caplan, L. R. (2010) ‘Medical complications after stroke’, The Lancet Neurology, 9:105–18.
56Anonymous (1996) ‘Chapter 2: The development of radiotherapy: physics, technology, methods’, Acta Oncologica, 35:24–30.
57Anonymous (1960) ‘Obituary: E. H. Grubbé, MD, FACP’, British Medical Journal, 2:609.
58Tanderup, K., Ménard, C., Polgar, C., Lindegaard, J. C., Kirisits, C. and Pötter, R. (2017) ‘Advancements in brachytherapy’, Advanced Drug Delivery Reviews, 109:15–25.
59Scott, A. (2015) ‘Non-sting barrier cream in radiotherapy-induced skin reactions’, British Journal of Nursing, 24:S32, S34–7.
60Travis, L. B. (2006) ‘The epidemiology of second primary cancers’, Cancer Epidemiology Biomarkers & Prevention, 15:2020–6.
61Taylor, C., Correa, C., Duane, F. K., Aznar, M. C., Anderson, S. J., Bergh, J., Dodwell, D., Ewertz, M., Gray, R., Jagsi, R., Pierce, L., Pritchard, K. I., Swain, S., Wang, Z., Wang, Y., Whelan, T., Peto, R. and McGale, P. (2017) ‘Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomized trials’, Journal of Clinical Oncology, 35:1641–9.
62Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., Rosenthal, M. A. and Eisenberger, M. A. (2004) ‘Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer’, New England Journal of Medicine, 351:1502–12.
63Khoja, L., McGurk, A., O’Hara, C., Chow, S. and Hasan, J. (2015) ‘Mortality within 30 days following systemic anti-cancer therapy: A review of all cases over a 4 year period in a tertiary cancer centre’, European Journal of Cancer, 51:233–40.
64Silverman, R., Smith, L. and Sundar, S. (2014) ‘Benchmarking 30 day mortality after palliative chemotherapy for solid tumours’, Clinical Oncology, 26:236.
65Karagöz Özen, D. S., Ozturk, M. A., Aydin, Ö., Turna, Z. H., Ilvan, S. and Özgüroglu, M. (2014) ‘Receptor expression discrepancy between primary and metastatic breast cancer lesions’, Oncology Research and Treatment, 37:622–6.
66Roth, M. Y. and Amory, J. K. (2016) ‘Beyond the condom: Frontiers in male contraception’, Seminars in Reproductive Medicine, 34:183–90.
67Sam, A. and Meeran, K. (2009) Lecture Notes in Endocrinology and Diabetes. Oxford: Wiley-Blackwell.
68Komatsu, H., Yagasaki, K., Yamauchi, H., Yamauchi, T. and Takebayashi, T. (2016) ‘A self-directed home yoga programme for women with breast cancer during chemotherapy: A feasibility study’, International Journal of Nursing Practice, 22:258–66.
69Atkins, L. and Fallowfield, L. (2006) ‘Intentional and non-intentional non-adherence to medication amongst breast cancer patients’, European Journal of Cancer, 42:2271–6.
70Ito, E., Nakano, S., Otsuka, M., Mibu, A., Karikomi, M., Oinuma, T. and Yamamoto, M. (2016) ‘Spontaneous breast cancer remission: A case report’, International Journal of Surgery Case Reports, 25:132–6.
71Papac, R. (1996) ‘Spontaneous regression of cancer’, Cancer Treatment Reviews, 22:395–423.
72Ventegodt, S., Jacobsen, S. and Merrick, J. (2009) ‘Clinical holistic medicine: A case of induced spontaneous remission in a patient with non-Hodgkin b-lymphoma’, Journal of Alternative Medcine Research, 1:101–10.
73Horii, R., Akiyama, F., Kasumi, F., Koike, M. and Sakamoto, G. (2005) ‘Spontaneous “healing” of breast cancer’, Breast Cancer, 12:140–4.
74Donnelly, L. (2015) ‘“Cure for terminal cancer” found in game-changing drugs’, Daily Telegraph. Available online at: <www.telegraph.co.uk/news/health/news/11641771/Cure-for-terminal-cancer-found-in-game-changing-drugs.html>
75Gorman, C. (2015) ‘Cancer Immunotherapy: The cutting edge gets sharper’, Scientific American. Available online at: <www.scientificamerican.com/article/cancer-immunotherapy-the-cutting-edge-gets-sharper>
76Greener, M. (2016) ‘Cancer immunotherapy: Should we believe the hype?’, Prescriber, 27:13–20.
77Pieters, T. (1993) ‘Interferon and its first clinical trial: Looking behind the scenes’, Medical History, 37:270–95.
78Wiemann, B. and Starnes, C. O. (1994) ‘Coley’s toxins, tumor necrosis factor and cancer research: A historical perspective’, Pharmacology & Therapeutics, 64:529–64.
79Farkona, S., Diamandis, E. P. and Blasutig, I. M. (2016) ‘Cancer immunotherapy: The beginning of the end of cancer?’, BMC Medicine, 14:1–18.
80Bracci, L., Schiavoni, G., Sistigu, A. and Belardelli, F. (2014) ‘Immune-based mechanisms of cytotoxic chemotherapy: Implications for the design of novel and rationale-based combined treatments against cancer’, Cell Death and Differentiation, 21:15–25.
81El-Osta, H., Shahid, K., Mills, G. M. and Peddi, P. (2016) ‘Immune checkpoint inhibitors: The new frontier in non-small-cell lung cancer treatment’, Onco Targets and Therapy, 9:5101–16.
82Kravits, K. G. (2015) ‘Hypnosis for the management of anticipatory nausea and vomiting’, Journal of the Advanced Practitioner in Oncology, 6:225–9.
83Chochinov, H. and Breitbart, W. (eds) (2009) Handbook of Psychiatry in Palliative Medicine. Oxford: Oxford University Press.
84Hammer, M. J., Ercolano, E. A., Wright, F., Dickson, V. V., Chyun, D. and Melkus, G. D. E. (2015) ‘Self-management for adult patients with cancer: an integrative review’, Cancer Nursing, 38:E10–E26.
85Malton, S. (2015) ‘Managing chemo side-effects’, Pharmacy Magazine, June:16.
86Ben-Arye, E., Polliack, A., Schiff, E., Tadmor, T. and Samuels, N. (2013) ‘Advising patients on the use of non-herbal nutritional supplements during cancer therapy: A need for doctor–patient communication’, Journal of Pain and Symptom Management, 46:887–96.
87Newton, S., Hickey, M. and Marrs, J. (2009) Mosby’s Oncology Nursing Advisor: A comprehensive guide to clinical practice. St. Louis, MO and London: Mosby.
88Armstrong, L. E., Ganio, M. S., Casa, D. J., Lee, E. C., McDermott, B. P., Klau, J. F., Jimenez, L., Le Bellego, L., Chevillotte, E. and Lieberman, H. R. (2012) ‘Mild dehydration affects mood in healthy young women’, The Journal of Nutrition, 142:382–8.
89Ganio, M. S., Armstrong, L. E., Casa, D. J., McDermott, B. P., Lee, E. C., Yamamoto, L. M., Marzano, S., Lopez, R. M., Jimenez, L., Le Bellego, L., Chevillotte, E. and Lieberman, H. R. (2011) ‘Mild dehydration impairs cognitive performance and mood of men’, British Journal of Nutrition, 106:1535–43.
90Wu, H.-S. and Harden, J. K. (2015) ‘Symptom burden and quality of life in survivorship: A review of the literature’, Cancer Nursing, 38:E29–E54.
91Priestman, T. (2007) Coping with Radiotherapy. London: Sheldon Press.
92Battaglini, C. L., Mills, R. C., Phillips, B. L., Lee, J. T., Story, C. E., Nascimento, M. G. B. and Hackney, A. C. (2014) ‘Twenty-five years of research on the effects of exercise training in breast cancer survivors: A systematic review of the literature’, World Journal of Clinical Oncology, 5:177–90.
93Borch, K. B., Braaten, T., Lund, E. and Weiderpass, E. (2015) ‘Physical activity before and after breast cancer diagnosis and survival: The Norwegian women and cancer cohort study’, BMC Cancer, 15:1–10.
94Sutton, A., Crew, A. and Wysong, A. (2016) ‘Redefinition of skin cancer as a chronic disease’, JAMA Dermatology, 152:255–6.
95Hofbauer, K., Anker, S., Inui, A. and Nicholson, J. (2005) Pharmacotherapy of Cachexia. Boca Raton, FL and London: CRC Press.
96Gamper, E.-M., Zabernigg, A., Wintner, L. M., Giesinger, J. M., Oberguggenberger, A., Kemmler, G., Sperner-Unterweger, B. and Holzner, B. (2012) ‘Coming to your senses: Detecting taste and smell alterations in chemotherapy patients: A systematic review’, Journal of Pain and Symptom Management, 44:880–95.
97Ijpma, I., Renken, R. J., ter Horst, G. J. and Reyners, A. K. L. (2015) ‘Metallic taste in cancer patients treated with chemotherapy’, Cancer Treatment Reviews, 41:179–86.
98Garland, S. N., Xie, S. X., Li, Q., Seluzicki, C., Basal, C. and Mao, J. J. (2017) ‘Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: A randomized trial’, Menopause, 24:517–23.
99Wiśniewska, I., Jochymek, B., Lenart-Lipińska, M. and Chabowski, M. (2016) ‘The pharmacological and hormonal therapy of hot flushes in breast cancer survivors’, Breast Cancer, 23:178–82.
100Chao, J. H. and Page, S. T. (2016) ‘The current state of male hormonal contraception’, Pharmacology & Therapeutics, 163:109–17.
101Dautricourt, S., Marzloff, V. and Dollfus, S. (2015) ‘Meningiomatosis revealed by a major depressive syndrome’, BMJ Case Reports, 2015:Doi:10.1136/bcr-2015-211909.
102Tylee, A. and Gandhi, P. (2005) ‘The importance of somatic symptoms in depression in primary care’, The Primary Care Companion for CNS Disorders, 7:167–76.
103Edwards, V. (2003) Depression: What you really need to know. London: Robinson.
104Russell, A. (2009) The Social Basis of Medicine (1st edn). Oxford: Wiley-Blackwell.
105Hoge, E. A., Ivkovic, A. and Fricchione, G. L. (2012) ‘Generalized anxiety disorder: Diagnosis and treatment’, BMJ, 345:e7500.
106Lin, Y.-H., Kao, C.-C., Wu, S.-F., Hung, S.-L., Yang, H.-Y. and Tung, H.-Y. (2017) ‘Risk factors of post-traumatic stress symptoms in patients with cancer’, Journal of Clinical Nursing, 26:3137–43.
107Tsai, T. J., Chung, U. L., Chang, C. J. and Wang, H. H. (2016) ‘Influence of religious beliefs on the health of cancer patients’, Asian Pacific Journal of Cancer Prevention, 17:2315–20.
108Kroenke, C. H., Michael, Y. L., Poole, E. M., Kwan, M. L., Nechuta, S., Leas, E., Caan, B. J., Pierce, J., Shu, X.-O., Zheng, Y. and Chen, W. Y. (2016) ‘Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project’, Cancer, 123:1228–37.
109Durdu Keskin, O., Kertmen, N., Karakas, Y., Babacan, T., Arik, Z., Altundag, K. and Gullu, I. (2015) ‘A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: The latest recurrence in the literature’, Journal of BUON, 20:348.